Alessandro Noseda

Alessandro Noseda currently works at RegeneRx Biopharmaceuticals, Inc., as Independent Director from 2019, Metheresis Translational Research SA, as Director, Thule Therapeutics SA, as Director, Rostaquo, as Director, Leadiant Biosciences, Inc., as Chief Medical Officer from 2018, Leadiant Biosciences SpA, as Chief Scientific Officer from 2017, and Essetifin SpA, as Chief Scientific Officer-Rare Disease Business.
Dr. Noseda also formerly worked at Leadiant Biosciences SA, as Chief Executive Officer from 2007 to 2017.
Dr. Noseda received his doctorate degree from Wake Forest School of Medicine and doctorate degree in 1984 from the University of Milan.